Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes

Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes

Purpose: To evaluate the safety of intravitreal injection of Stivant, a biosimilar to bevacizumab, in rabbits using electrophysiological and histological analysis. Methods: Both eyes of 41 New Zealand albino rabbits were injected with 0.1 mL (2.5 mg) of Stivant. The rabbits were scheduled to b...

Full description

Bibliographic Details
Main Authors: Alireza Lashay, Hooshang Faghihi, Ahmad Mirshahi, Hassan Khojasteh, Alireza Khodabande, Hamid Riazi-Esfahani, Fahimeh Asadi Amoli, Elias Khalili Pour, Elham Delrish
Format: Article
Language:English
Published: Knowledge E 2020-08-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
biosimilar
intravitreal injection
safety
stivant
Online Access:https://doi.org/10.18502/jovr.v15i3.7453

Internet

https://doi.org/10.18502/jovr.v15i3.7453

Similar Items